Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$421K Sell
1,578
-30
-2% -$8.3K 0.12% 145
2025
Q4
$442K Sell
1,608
-61
-4% -$17.1K 0.12% 144
2025
Q3
$481K Sell
1,669
-110
-6% -$32.5K 0.13% 137
2025
Q2
$588K Sell
1,779
-185
-9% -$59.6K 0.17% 116
2025
Q1
$646K Hold
1,964
0.2% 109
2024
Q4
$542K Sell
1,964
-9
-0.5% -$2.87K 0.16% 116
2024
Q3
$683K Hold
1,973
0.2% 106
2024
Q2
$652K Hold
1,973
0.2% 102
2024
Q1
$716K Sell
1,973
-217
-10% -$71.4K 0.21% 100
2023
Q4
$656K Sell
2,190
-5
-0.2% -$1.46K 0.2% 102
2023
Q3
$628K Sell
2,195
-100
-4% -$28.5K 0.21% 99
2023
Q2
$644K Sell
2,295
-18
-0.8% -$4.69K 0.21% 101
2023
Q1
$591K Buy
2,313
+155
+7% +$45.2K 0.2% 105
2022
Q4
$715K Sell
2,158
-233
-10% -$73.7K 0.25% 91
2022
Q3
$663K Hold
2,391
0.24% 93
2022
Q2
$630K Sell
2,391
-13
-0.5% -$3.35K 0.21% 99
2022
Q1
$576K Sell
2,404
-167
-6% -$39.1K 0.17% 119
2021
Q4
$590K Sell
2,571
-17
-0.7% -$3.61K 0.16% 119
2021
Q3
$518K Buy
2,588
+60
+2% +$13K 0.16% 121
2021
Q2
$599K Sell
2,528
-115
-4% -$28.7K 0.18% 109
2021
Q1
$639K Buy
2,643
+53
+2% +$11.8K 0.2% 105
2020
Q4
$539K Sell
2,590
-344
-12% -$67.5K 0.18% 117
2020
Q3
$497K Buy
+2,934
New +$516K 0.18% 114
2019
Q4
Sell
-1,395
Closed -$212K 178
2019
Q3
$212K Buy
1,395
+124
+10% +$20.2K 0.13% 132
2019
Q2
$200K Buy
+1,271
New +$199K 0.12% 138
2019
Q1
Sell
-1,189
Closed -$226K 137
2018
Q4
$226K Buy
+1,189
New +$248K 0.16% 114

Other funds holding CI

Roberts, Glore & Co's CI Position: Q1 2026 in Review

Roberts, Glore & Co reduced its Cigna (CI) stake by 1.9% in Q1 2026, selling an estimated $8.3K and leaving 1,578 shares worth $421K. The position accounts for 0.12% of the portfolio, ranked #145.

Roberts, Glore & Co first reported a position in CI in Q4 2018 and has held it in 26 quarters since. The position peaked at $716K in Q1 2024. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Roberts, Glore & Co held 1,578 shares of Cigna worth $421K as of Q1 2026.
  • Roberts, Glore & Co sold 30 Cigna shares in Q1 2026, an estimated $8.3K.
  • Cigna made up 0.12% of Roberts, Glore & Co's portfolio in Q1 2026, its #145 holding.
  • Roberts, Glore & Co first reported a position in Cigna in Q4 2018 and has held it in 26 quarters since.
  • Roberts, Glore & Co's Cigna position peaked at $716K in Q1 2024.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Roberts, Glore & Co's 13F filing for Q1 2026, filed 4 May 2026.